The Lobo’s style is a nod to the old-school, low-rider culture of street trucks. Though not slammed, it’s an inch or so lower ...

Rivian still has a long way to go in proving that it can be a big competitor in the EV space. An increase in competition in ...

Medline shares surged in their trading debut Wednesday, after the medical supply company raised $6.26 billion in one of the biggest initial public offerings in recent years.

Against that backdrop, we ran Rivian through an AI price-prediction agent powered by OpenAI's GPT. This forecast focuses squarely on Dec. 12 – Dec. 31, 2025, blending recent price action with ...

Rivian stock had been trending upward recently despite facing challenges. Here is a look at where the stock could be in a ...

At $6.26 billion, Medline is just the fifth US-listed firm to raise more than $5 billion in an IPO over the past decade, data ...

AI Impact highlights Rivian’s autonomy strategy, hybrid AI gains in healthcare, AGI skepticism, exec moves and AI Impact ...

Rivian is making some big moves into autonomy and AI, but its success in EVs will likely come from selling cheaper vehicles.

Discover why Polestar stock faces a sell rating amid ongoing losses, missed targets, and challenging EV demand.

During a recent podcast interview, Rivian CEO RJ Scaringe also claimed that Rivian owners rarely complain about the lack of ...

Medline, a medical-supplies manufacturer and distributor, raised $6.26 billion in its initial public offering, notching the largest IPO since 2021. The Blackstone- and Carlyle\-backed company sold 216 ...

While AI updates are crucial for the stock, the firm noted that the company’s R2 SUV is the main reason for its bullish ...